Liposome Assisted Drug Delivery Market Report

Global and Region Liposome Assisted Drug Delivery Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：193
  • REPORT CODE：GMM952067
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Liposome Assisted Drug Delivery market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Liposome Assisted Drug Deliverymarket, defines the market attractiveness level of Liposome Assisted Drug Delivery market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Liposome Assisted Drug Delivery industry, describes the types of Liposome Assisted Drug Delivery market, the applications of major players and the market size, and deeply analyzes the current situation of the global Liposome Assisted Drug Delivery market and the development prospects and opportunities of Liposome Assisted Drug Delivery industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Liposome Assisted Drug Delivery market in Chapter 13.

    By Player:

    • Pacira

    • Johnson & Johnson

    • Sigma-Tau Group

    • Luye Pharma

    • CSPC

    • Gilead Sciences

    • Teva Pharmaceutical

    • Novartis

    • Fudan-Zhangjiang

    • Ipsen (Onivyde)

    • Sun Pharmaceutical

    By Type:

    • Liposomal Doxorubicin

    • Liposomal Amphoteracin B

    • Liposomal Paclitaxel

    • Others

    By End-User:

    • Fungal Infection Therapy

    • Cancer & Tumor Therapy

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Liposome Assisted Drug Delivery Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Liposome Assisted Drug Delivery Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Liposome Assisted Drug Delivery Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Liposome Assisted Drug Delivery Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Liposome Assisted Drug Delivery Market Analysis and Outlook to 2022

    • 7.1 Global Liposome Assisted Drug Delivery Consumption (2017-2022)

    • 7.2 United States Liposome Assisted Drug Delivery Consumption (2017-2022)

    • 7.3 Europe Liposome Assisted Drug Delivery Consumption (2017-2022)

    • 7.4 China Liposome Assisted Drug Delivery Consumption (2017-2022)

    • 7.5 Japan Liposome Assisted Drug Delivery Consumption (2017-2022)

    • 7.6 India Liposome Assisted Drug Delivery Consumption (2017-2022)

    • 7.7 South Korea Liposome Assisted Drug Delivery Consumption (2017-2022)

    8 Region and Country-wise Liposome Assisted Drug Delivery Market Analysis and Outlook to 2028

    • 8.1 Global Liposome Assisted Drug Delivery Consumption Forecast (2022-2028)

    • 8.2 United States Liposome Assisted Drug Delivery Consumption Forecast (2022-2028)

    • 8.3 Europe Liposome Assisted Drug Delivery Consumption Forecast (2022-2028)

    • 8.4 China Liposome Assisted Drug Delivery Consumption Forecast (2022-2028)

    • 8.5 Japan Liposome Assisted Drug Delivery Consumption Forecast (2022-2028)

    • 8.6 India Liposome Assisted Drug Delivery Consumption Forecast (2022-2028)

    • 8.7 South Korea Liposome Assisted Drug Delivery Consumption Forecast (2022-2028)

    9 Global Liposome Assisted Drug Delivery Market Outlook by Types and Applications to 2022

    • 9.1 Global Liposome Assisted Drug Delivery Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Liposomal Amphoteracin B Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Liposomal Paclitaxel Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Liposome Assisted Drug Delivery Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Fungal Infection Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer & Tumor Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Liposome Assisted Drug Delivery Market Outlook by Types and Applications to 2028

    • 10.1 Global Liposome Assisted Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Liposomal Amphoteracin B Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Liposomal Paclitaxel Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Liposome Assisted Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Fungal Infection Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer & Tumor Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Liposome Assisted Drug Delivery Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Liposome Assisted Drug Delivery Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Liposome Assisted Drug Delivery Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Liposome Assisted Drug Delivery Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Liposome Assisted Drug Delivery Market Competitive Analysis

    • 14.1 Pacira

      • 14.1.1 Pacira Company Details

      • 14.1.2 Pacira Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pacira Liposome Assisted Drug Delivery Product and Service

    • 14.2 Johnson & Johnson

      • 14.2.1 Johnson & Johnson Company Details

      • 14.2.2 Johnson & Johnson Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Johnson & Johnson Liposome Assisted Drug Delivery Product and Service

    • 14.3 Sigma-Tau Group

      • 14.3.1 Sigma-Tau Group Company Details

      • 14.3.2 Sigma-Tau Group Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sigma-Tau Group Liposome Assisted Drug Delivery Product and Service

    • 14.4 Luye Pharma

      • 14.4.1 Luye Pharma Company Details

      • 14.4.2 Luye Pharma Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Luye Pharma Liposome Assisted Drug Delivery Product and Service

    • 14.5 CSPC

      • 14.5.1 CSPC Company Details

      • 14.5.2 CSPC Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 CSPC Liposome Assisted Drug Delivery Product and Service

    • 14.6 Gilead Sciences

      • 14.6.1 Gilead Sciences Company Details

      • 14.6.2 Gilead Sciences Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Gilead Sciences Liposome Assisted Drug Delivery Product and Service

    • 14.7 Teva Pharmaceutical

      • 14.7.1 Teva Pharmaceutical Company Details

      • 14.7.2 Teva Pharmaceutical Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Teva Pharmaceutical Liposome Assisted Drug Delivery Product and Service

    • 14.8 Novartis

      • 14.8.1 Novartis Company Details

      • 14.8.2 Novartis Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novartis Liposome Assisted Drug Delivery Product and Service

    • 14.9 Fudan-Zhangjiang

      • 14.9.1 Fudan-Zhangjiang Company Details

      • 14.9.2 Fudan-Zhangjiang Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Fudan-Zhangjiang Liposome Assisted Drug Delivery Product and Service

    • 14.10 Ipsen (Onivyde)

      • 14.10.1 Ipsen (Onivyde) Company Details

      • 14.10.2 Ipsen (Onivyde) Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Ipsen (Onivyde) Liposome Assisted Drug Delivery Product and Service

    • 14.11 Sun Pharmaceutical

      • 14.11.1 Sun Pharmaceutical Company Details

      • 14.11.2 Sun Pharmaceutical Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Sun Pharmaceutical Liposome Assisted Drug Delivery Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Liposome Assisted Drug Delivery

    • Figure Liposome Assisted Drug Delivery Picture

    • Table Global Liposome Assisted Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Liposome Assisted Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Liposome Assisted Drug Delivery Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Liposome Assisted Drug Delivery Consumption by Country (2017-2022)

    • Figure United States Liposome Assisted Drug Delivery Consumption and Growth Rate (2017-2022)

    • Table Europe Liposome Assisted Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure China Liposome Assisted Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Japan Liposome Assisted Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure India Liposome Assisted Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure South Korea Liposome Assisted Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Global Liposome Assisted Drug Delivery Consumption Forecast by Country (2022-2028)

    • Figure United States Liposome Assisted Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Liposome Assisted Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Liposome Assisted Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Liposome Assisted Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Liposome Assisted Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Liposome Assisted Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)

    • Figure Global Liposomal Amphoteracin B Consumption and Growth Rate (2017-2022)

    • Figure Global Liposomal Paclitaxel Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Fungal Infection Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer & Tumor Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liposomal Amphoteracin B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liposomal Paclitaxel Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fungal Infection Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer & Tumor Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Liposome Assisted Drug Delivery Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Liposome Assisted Drug Delivery Export by Region (Top 5 Countries) (2017-2028)

    • Table Pacira (Foundation Year, Company Profile and etc.)

    • Table Pacira Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pacira Liposome Assisted Drug Delivery Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Liposome Assisted Drug Delivery Product and Service

    • Table Sigma-Tau Group (Foundation Year, Company Profile and etc.)

    • Table Sigma-Tau Group Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sigma-Tau Group Liposome Assisted Drug Delivery Product and Service

    • Table Luye Pharma (Foundation Year, Company Profile and etc.)

    • Table Luye Pharma Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Luye Pharma Liposome Assisted Drug Delivery Product and Service

    • Table CSPC (Foundation Year, Company Profile and etc.)

    • Table CSPC Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSPC Liposome Assisted Drug Delivery Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Liposome Assisted Drug Delivery Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Liposome Assisted Drug Delivery Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Liposome Assisted Drug Delivery Product and Service

    • Table Fudan-Zhangjiang (Foundation Year, Company Profile and etc.)

    • Table Fudan-Zhangjiang Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fudan-Zhangjiang Liposome Assisted Drug Delivery Product and Service

    • Table Ipsen (Onivyde) (Foundation Year, Company Profile and etc.)

    • Table Ipsen (Onivyde) Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ipsen (Onivyde) Liposome Assisted Drug Delivery Product and Service

    • Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Liposome Assisted Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Liposome Assisted Drug Delivery Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US